- Home
- EXK vs CLDX Comparison
EXK vs CLDX Comparison
Compare EXK & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXK | CLDX |
|---|---|---|
| Founded | 1981 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | EXK | CLDX |
|---|---|---|
| Price | $9.33 | $31.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $13.94 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 7.7M | 616.4K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $69.59 | $111.39 |
| Revenue Next Year | $17.61 | $235.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $3.50 | $18.56 |
| 52 Week High | $15.15 | $35.83 |
Technical Indicators
Market Signals| Indicator | EXK | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 49.07 |
| Support Level | $8.47 | $31.65 |
| Resistance Level | $10.40 | $35.10 |
| Average True Range (ATR) | 0.63 | 1.39 |
| MACD | -0.09 | -0.17 |
| Stochastic Oscillator | 16.39 | 43.21 |
Price Performance
Historical ComparisonAbout EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.